Fetal growth and development disorders in smoking pregnant women

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: Due to the increased frequency of smoking in pregnant women, an interest in the study of the mechanisms of the fetoplacental unit in women with tobacco addiction has also been increased all over the world. The effect of low degrees of tobacco addiction of a pregnant woman on the fetus has not been studied in the available literature.

AIM: The aim of this study was to identify the growth and developmental abnormalities of the fetus at 30-34 weeks of gestation in smoking pregnant women at the third-trimester ultrasound screening.

MATERIALS AND METHODS: Pregnant women, who were observed in the Northern Medical Clinical Center named after N.A. Semashko, Arkhangelsk, Russia were examined during the ultrasound screening. A continuous examination of pregnant women with three ultrasound screenings was carried out, with the third screening performed in 1048 individuals.

RESULTS: The survey cohort included 120 pregnant women using the inclusion criteria. Two groups were formed depending on the presence or absence of smoking during pregnancy. The first group contained non-smoking pregnant women (n = 40); the second group comprised smokers during pregnancy (n = 80). Comparison of fetal development parameters in the group of pregnant smokers was carried out in two subgroups: the second “a” subgroup only consisted of smokers in the first trimester (embryonic period) and the second “b” subgroup contained smokers throughout pregnancy. All pregnant women who took part in the study signed a Patient Informed Consent form. The study design was observational, cross-sectional (one-step). The main manifestations of fetal growth and development disorders at 30-34 weeks of gestation in pregnant smokers were low estimated fetal weight, low tubular bone length and low head circumference by the gestational age. Low (below the 10th percentile) estimated fetal weight by the gestational age was recorded only in the group of pregnant women who smoke (p = 0.001) and in 90.0% of cases even with a weak degree of tobacco addiction. It was accompanied by low bone sizes and was detected in 10.0% of cases among women who stopped smoking in the first trimester and in 15.0% of cases among those who continued to smoke throughout pregnancy. This result confirmed early symmetrical intrauterine growth restriction of the fetus. Pregnant smokers at 30-34 weeks of gestation had significantly more often low (below the 5th percentile) fetometric parameters characterizing bone growth: femur length (p = 0.01), shinbone length (p = 0.035), shoulder bone length (p = 0.004), biparietal head size (p = 0.006), and head circumference (p = 0.002). Low values of the fetal head circumference were found in 50.0% of cases among pregnant smokers. In the absence of signs of fetal bone growth restriction and the estimated fetal weight in P10-95 values in the group of smoking pregnant women, significantly more often (p = 0.027) than in non-smokers, low (below the 5th percentile) head circumference for gestational age was recorded in 29.8% of cases. In addition, in this group of fetuses of pregnant smokers, elevated ratios of abdominal circumference to head circumference were found, which indicated fetal head growth restriction. The fetometry data obtained were confirmed by anthropometric measurements in the newborns during term delivery, the length of full-term newborns in pregnant smokers being significantly lower (p = 0.040).

CONCLUSIONS: Fetuses of pregnant smokers were more likely to have low fetometric parameters by gestational age. Low estimated weights of the fetuses were found in 90.0% of cases with a weak degree of tobacco addiction.

About the authors

Ekaterina M. Gryzunova

Northern Medical Clinical Center named after N.A. Semashko

Email: gryzunova.ekaterina@yandex.ru
Russian Federation, Arkhangelsk

Alexey N. Baranov

Northern State Medical University

Author for correspondence.
Email: a.n.baranov2011@yandex.ru

MD, Dr. Sci. (Med.), Professor

Russian Federation, Arkhangelsk

Andrey G. Solovyov

Northern State Medical University

Email: asoloviev1@yandex.ru

MD, Dr. Sci. (Med.), Professor

Russian Federation, Arkhangelsk

Elena V. Kazakevich

Northern Medical Clinical Center named after N.A. Semashko

Email: secretary@nmcs.ru

MD, Dr. Sci. (Med.), Professor

Russian Federation, Arkhangelsk

Galina N. Chumakova

Northern State Medical University

Email: zelchum-neo@yandex.ru

MD, Dr. Sci. (Med.), Professor

Russian Federation, Arkhangelsk

Larisa G. Kiselyova

Northern State Medical University

Email: kis272@yandex.ru

MD, Cand. Sci. (Med.), Assistant Professor

Russian Federation, Arkhangelsk

References

  1. Bessolova NA, Kiseleva LG, Chumakova GN, Soloviev AG. Effect of pregnant women nicotine dependence on fetus development and newborn adaptation. Narkologija. 2008;(11):49–52. (In Russ.)
  2. Baba S, Wikström AK, Stephansson O, Cnattingius S. Changes in snuff and smoking habits in Swedish pregnant women and risk for small for gestational age births. BJOG. 2013;120(4):456–462. doi: 10.1111/1471-0528.12067
  3. Gupta PC, Subramoney S. Smokeless tobacco use and risk of stillbirth: a cohort study in Mumbai, India. Epidemiology. 2006;17(1):47–51. doi: 10.1097/01.ede.0000190545.19168.c4
  4. Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P; International Small for Gestational Age Advisory Board. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics. 2003;111(6 Pt 1):1253–1261. doi: 10.1542/peds.111.6.1253
  5. Ishikawa H, Seki R, Yokonishi S, et al. Relationship between fetal weight, placental growth and litter size in mice from mid- to late-gestation. Reprod Toxicol. 2006;21(3):267–270. doi: 10.1016/j.reprotox.2005.08.002
  6. Suhag A, Berghella V. Intrauterine Growth Restriction (IUGR): Etiology and diagnosis. Curr Obstet Gynecol Rep. 2013;2:102–111. doi: 10.1007/s13669-013-0041-z
  7. Klinicheskie rekomendacii. Akusherstvo i ginekologija. Ed. by VN Serov, GT Suhih. 4th ed. Moscow: GEOTAR-Media; 2014. (In Russ.)
  8. Institute of Obstetricians Gynaecologists, Royal College of Physicians of Ireland; Health Service Executive. [Internet]. Fetal growth restriction — recognition, diagnosis and management: Clinical practice guideline. 2014. [cited 2021 Apr 25]. Available from: https://www.hse.ie/eng/services/publications/clinical-strategy-and-programmes/fetal-growth-restriction.pdf
  9. Sexton M, Hebel JR. A clinical trial of change in maternal smoking and its effect on birth weight. JAMA. 1984;251(7):911–915. doi: 10.1001/jama.1984.03340310025013
  10. Mitchell EA, Thompson JM, Robinson E, et al. Smoking, nicotine and tar and risk of small for gestational age babies. Acta Paediatr. 2002;91(3):323–328. doi: 10.1080/08035250252834003
  11. Merc Je. Ul’trazvukovaja diagnostika v akusherstve i ginekologii: in 2 vol. Ed. by AI Gus. Moscow: MEDpress-inform; 2011. (In Russ.)
  12. Semenova TV, Arzhanova ON, Bespalova ON, et al. Peculiarities of pregnancy course and pregnancy outcomes in tobacco smoking. Journal of obstetrics and women’s diseases. 2014;(2):50–58. (In Russ.). doi: 10.17816/JOWD63250-58
  13. Fadeeva NI, Burjakova SI. Antenatal’nyj monitoring pri zaderzhke rosta ploda v prognozirovanii tjazhelyh perinatal’nyh porazhenij CNS nedonoshennyh novorozhdennyh. Prenatal’naja diagnostika. 2014;(3):268–269. (In Russ.)
  14. Esposito ER, Horn KH, Greene RM, Pisano MM. An animal model of cigarette smoke-induced in utero growth retardation. Toxicology. 2008;246(2–3):193–202. doi: 10.1016/j.tox.2008.01.014
  15. O sovershenstvovanii prenatal’noj diagnostiki v profilaktike nasledstvennyh i vrozhdennyh zabolevanij u detej: prikaz Ministerstva zdravoohranenija Rossijskoj Federacii No. 457 of 28 December 2000. (In Russ.). [cited 2020 Dec 16]. Available from: http://docs.cntd.ru/document/901781668
  16. Shepard MJ, Richards VA, Berkowitz RL, et al. An evaluation of two equations for predicting fetal weight by ultrasound. Am J Obstet Gynecol. 1982;142(1):47–54. doi: 10.1016/s0002-9378(16)32283-9
  17. Kho EM, North RA, Chan E, et al. Changes in Doppler flow velocity waveforms and fetal size at 20 weeks gestation among cigarette smokers. BJOG. 2009;116(10):1300–1306. doi: 10.1111/j.1471-0528.2009.02266.x
  18. Pringle PJ, Geary MP, Rodeck CH, et al. The influence of cigarette smoking on antenatal growth, birth size, and the insulin-like growth factor axis. J Clin Endocrinol Metab. 2005;90(5):2556–2562. doi: 10.1210/jc.2004-1674
  19. Sastry BV. Placental toxicology: tobacco smoke, abused drugs, multiple chemical interactions, and placental function. Reprod Fertil Dev. 1991;3(4):355–372. doi: 10.1071/rd9910355
  20. Jaddoe VW, Troe EJ, Hofman A, et al. Active and passive maternal smoking during pregnancy and the risks of low birthweight and preterm birth: the Generation R Study. Paediatr Perinat Epidemiol. 2008;22(2):162–171. doi: 10.1111/j.1365-3016.2007.00916.x
  21. Jaddoe VW, Verburg BO, de Ridder MA, et al. Maternal smoking and fetal growth characteristics in different periods of pregnancy: the generation R study. Am J Epidemiol. 2007;165(10):1207–1215. doi: 10.1093/aje/kwm014
  22. Stein AD, Ravelli AC, Lumey LH. Famine, third-trimester pregnancy weight gain, and intrauterine growth: the Dutch Famine Birth Cohort Study. Hum Biol. 1995;67(1):135–150.
  23. Krivcova LA, Horoshkina LA. Zdorov’e detej ot materej s priznakami nikotinovoj i alkogol’noj zavisimosti. Narkologija. 2011;(11):67–71. (In Russ.)
  24. Suzuki K, Shinohara R, Sato M, et al. Association between maternal smoking during pregnancy and birth weight: An appropriately adjusted model from the Japan environment and children’s study. J Epidemiol. 2016;26(7):371–377. doi: 10.2188/jea.JE20150185
  25. Mukhopadhyay P, Horn KH, Greene RM, Michele Pisano M. Prenatal exposure to environmental tobacco smoke alters gene expression in the developing murine hippocampus. Reprod Toxicol. 2010;29(2):164–175. doi: 10.1016/j.reprotox.2009.12.001
  26. Roy TS, Seidler FJ, Slotkin TA. Prenatal nicotine exposure evokes alterations of cell structure in hippocampus and somatosensory cortex. J Pharmacol Exp Ther. 2002;300(1):124–133. doi: 10.1124/jpet.300.1.124
  27. El Marroun H, Schmidt MN, Franken IH, et al. Prenatal tobacco exposure and brain morphology: a prospective study in young children. Neuropsychopharmacology. 2014;39(4):792–800. doi: 10.1038/npp.2013.273
  28. Roza SJ, Verburg BO, Jaddoe VW, et al. Effects of maternal smoking in pregnancy on prenatal brain development. The Generation R Study. Eur J Neurosci. 2007;25(3):611–617. doi: 10.1111/j.1460-9568.2007.05393.x
  29. Król M, Florek E, Piekoszewski W, et al. The impact of intrauterine tobacco exposure on the cerebral mass of the neonate based on the measurement of head circumference. Brain Behav. 2012;2(3):243–248. doi: 10.1002/brb3.49
  30. Lee KW, Richmond R, Hu P, et al. Prenatal exposure to maternal cigarette smoking and DNA methylation: epigenome-wide association in a discovery sample of adolescents and replication in an independent cohort at birth through 17 years of age. Environ Health Perspect. 2015;123(2):193–199. doi: 10.1289/ehp.1408614.
  31. Suter M, Ma J, Harris A, et al. Maternal tobacco use modestly alters correlated epigenome-wide placental DNA methylation and gene expression. Epigenetics. 2011;6(11):1284–1294. doi: 10.4161/epi.6.11.17819

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Eсо-Vector



Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».